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operatively obtained, segmented, and reconstructed in 3D. During the procedure, the 3D
CT images, EAM data and real-time catheter position were imported into a custom work-
station. The electrophysiologist was blinded to these images, but the accuracy of the reg-
istration of these datasets was assessed prospectively by a second operator.
Results: Simulations were used to investigate 6 registration strategies employing a com-
bination of the descending Ao, PVs, and LA. The optimal strategy involved registering
points from both the Ao and LA; this resulted in an average distance from EA point to LA
image surface of 1.82 mm. To validate the in vivo registration, the catheter was localized
to the PV ostia on the registered CT image (confirmed by contrast injections under fluo-
roscopy). Also, after proper registration, the ridge between the LSPV and the LA append-
age was co-localized in both the CT and EAM datasets.
Conclusions: This study supports the feasibility of the general hypothesis that registra-
tion of pre-acquired cardiac images with real-time EA mapping can guide catheter move-
ment in the LA in a reliable and clinically-relevant manner.
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1053-209 Amiodarone in Survivors of Life-Threatening Ventricular 
Arrhythmias: Does It Improve Outcome? Results of the 
Leiden Out of Hospital Cardiac Arrest Trial (LOHCAT)
Philippine Kiès, Jeroen J. Bax, Alida E. Borger van der Burg, Eric Boersma, Marianne 
Bootsma, Lieselot van Erven, Ernst E. van der Wall, Martin J. Schalij, Leiden University 
Medical Center, Leiden, The Netherlands, Erasmus Medical Center, Rotterdam, The 
Netherlands
Introduction: Survivors of life-threatening ventricular arrhythmias (VA) are at increased
risk of death and recurrences. One-fourth of patients is discharged with amiodarone as
primary therapy or in addition to an implantable cardioverter defibrillator (ICD). The aim
of this study was to establish the effect of amiodarone on death and on the composite
endpoint of death and recurrences.
Methods: A total number of 417 consecutive survivors of life-threatening VA (328 male,
age 59±13 years) were included in a standardized screening and evaluation protocol to
determine the underlying pathology and optimise patient-tailored therapy. Multivariable
Cox’ regression analysis was performed to evaluate the relation between amiodarone
and survival and the composite endpoint of survival and recurrences. We adjusted for left
ventricular (LV) ejection fraction, LV dimensions, age, ischemic heart disease, inducibility
at electrophysiological test, revascularization, ICD and several other drugs.
Results: The majority of patients had ischemic heart disease (296, 71%). During follow-
up (32±25 months), 45 (10%) patients died (31 heart failure, 4 sudden death, 10 non-car-
diac). Amiodarone was administered in 110 (26%) patients, of whom 22 (20%) died, as
compared to 23 deaths (7.5%) in the patients without amiodarone (crude hazard ratio
(HR) 3.4, 95% CI 1.9-6, P<0.001). After adjustment for the previously mentioned vari-
ables, amiodarone still was associated with an increased risk on long-term mortality
(adjusted HR 3.7, 95% CI 1.1-12.6, P=0.03). Similar results were found for the composite
endpoint of death and/ or recurrences (crude HR 2.6, 95% CI 1.9-3.6, P<0.001 and
adjusted HR 1.9, 95% CI 1.1-3.2, P=0.03). Furthermore, this relation was found in
patients with and without ischemic heart disease.
Conclusion: Amiodarone may be associated with an increased risk of death (and recur-
rences), both in patients with and without ischemic heart disease. In view of these data, it
can be questioned whether amiodarone improves long-term outcome in survivors of life-
threatening VA.
1053-210 Incidence and Prognosis of Ventricular Tachycardia and 
Ventricular Fibrillation After Non-ST Elevation Acute 
Coronary Syndromes: Insights From the Global 
Registry of Acute Coronary Events
Álvaro Avezum, Marcos Knobel, Robert J. Goldberg, Immad Sadiq, Gordon Saperia, 
Tristam Smyth, Richard Paoloni, David Brieger, Polina Kuznetsova, Joel M. Gore, The 
GRACE Investigators, CTIA Hospital Albert Einstein, Sao Paulo, Brazil, University of 
Massachusetts Medical School, Worcester, MA
Background The incidence and prognosis of malignant ventricular arrhythmias (VA)
among patients with non-ST elevation acute coronary syndromes (NSTE-ACS) in clinical
practice is unknown. Most available data come from selected randomized clinical trials,
suggesting increased in-hospital and post-discharge mortality. The aim of this study was
to examine the incidence, predictors and outcomes of VA (ventricular tachycardia, ven-
tricular fibrillation and cardiac arrest) among patients with NSTE-ACS.
Methods We evaluated 17,545 patients with NSTE-ACS (non-ST elevation myocardial
infarction and unstable angina) from the Global Registry of Acute Coronary Events
(GRACE), and compared those who developed VA and increased hospital mortality to
those who did not. Adjustment for other risk factors related to increased mortality was
performed. Independent predictors of in-hospital VA were analyzed through multivariate
logistic regression modeling.
Results Presence of VA remained statistically significant after adjustment for demo-
graphics, treatment and clinical factors in a multivariate logistic model.
Conclusions In an unselected NSTE-ACS population from the observational GRACE
registry, the occurrence of in-hospital ventricular arrhythmic events was independently
associated with substantially higher in-hospital mortality. Prompt identification of predic-
tors of arrhythmic events and implementation of effective therapies are needed to
improve the survival of those patients. 
1053-211 A Multicenter Study of Depression as a Predictor for 
Appropriate Shocks Among Patients With Implantable 
Cardioverter Defibrillators
William Whang, Christine M. Albert, Rachel Lampert, Samuel F. Sears, Jr., Jamie B. 
Conti, Paul J. Wang, Jeremy N. Ruskin, James E. Muller, Murray A. Mittleman, 
Massachusetts General Hospital, Boston, MA
Background: Depression predicts mortality in patients with coronary artery disease
(CAD), but whether this is due to ventricular arrhythmia (VT/VF) is unknown.
Methods: To address this question, we prospectively examined the relationship between
baseline symptoms of depression and risk of VT/VF resulting in ICD discharge in the
Triggers of Ventricular Arrhythmias (TOVA) study. Symptoms were assessed by the Cen-
ter for Epidemiologic Studies-Depression (CES-D) scale. Scores of 16 to 27 and >27 rep-
resented mild and moderate to severe depression, respectively. Proportional hazards
models tested for associations among 1) all patients and 2) CAD patients, with adjust-
ment for prior shocks, age, sex, smoking, alcohol, hypertension, angina and CHF class,
and LVEF.
Results: Among 625 patients followed a median 186 days, 45 received ICD shocks for
VT/VF. Depression (CES-D score>16) was present in 111 (17.8%). Depression severity
was significantly related to VT/VF among all patients and among those in the CAD sub-
group (table). As compared to those without depression (CES-D score<16), the risk of
VT/VF was significantly elevated among patients with moderate to severe depression
(CES-D score>27), particularly among those with CAD who had a 7-fold increased risk of
VT/VF.
Conclusion: Depression severity predicts shocks for VT/VF among ICD patients. The
elevated risk of VT/VF may explain, at least in part, the higher cardiovascular mortality
observed in depressed patients, particularly those with CAD. 
1053-212 Temporal Patterns of Ventricular Tachyarrhythmia 
Recurrences Follow a Weibull Distribution
Mark Wood, Amy Xia, Xiaohong Zhou, Vasant Padmanabhan, Kenneth Ellenbogen, 
Medical College of Virginia, Richmond, VA, Medtronic, Inc., Minneapolis, MN
BACKGROUND: Understanding the temporal pattern of arrhythmias is essential to prop-
erly assess the response to antiarrhythmic therapies. Commonly used statistical mea-
sures usually assume a uniformly random pattern of tachyarrhythmias (VT) over time.
Table 1: Outcomes in NSTEMI/Unstable Angina Patients with Ventricular Arrhythmias
VT/VF CA VT/VF/
CA
No VT/VF/
CA
P value
Number of patients (% of 
total)
487 (2.8) 618 (3.6) 869 (5) 16,582 (95)
Death (%) 192 (40) 499 (81) 527 (61) 243 (2) <0.0001
OR 95% CI
In-hospital death (GRACE risk model) 75.0 59.1-94.5
VT, ventricular tachycardia; VF, ventricular fibrillation; CA, cardiac arrest
Table 2: Predictors of Ventricular Arrhythmia (Logistic Model)
OR 95% CI
In-hospital congestive heart failure 3.4 2.80-4.14
ST-segment deviation 1.4 1.16-1.61
Killip (per 1-class increase) 1.3 1.12-1.43
Pulse (per 30-bpm increase) 1.3 1.13-1.38
Initial serum creatinine (per 1-unit increase) 1.2 1.11-1.25
Initial cardiac enzymes 1.2 1.03-1.44
Age (per 10-year increase) 1.1 1.04-1.19
History of hypertension 0.8 0.69-0.96
Male 0.8 0.66-0.94
History of percutaneous coronary intervention 0.6 0.50-0.83
Hazard Ratios (95% CI) for VT/VF, Multivariable Analyses
All Patients
(n=625)
Patients with CAD
(n=465)
CES-D > 16 and < 27 1.58 (0.69 - 3.65) 1.96 (0.80 - 4.85)
CES-D > 27 4.06 (1.32 - 12.46) 7.55 (2.15 - 26.56)
P for trend 0.017 0.002
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The objective of this study was to test whether the temporal patterns of VT recurrences in
patients with implantable cardioverter-defibrillator (ICD) follow a random or a clustered
pattern by mathematical modeling. METHODS: Data analysis was conducted using the
Medtronic Gem DR database of 521 ICD patients. Patients with > 3 spontaneous VT
detections during follow up were studied. The times between consecutive treated VT
detections (inter-event interval) for each patient were compared to an exponential model
of random recurrences and a Weibull model to test for clustering of recurrences.
RESULTS: 71 patients had > 3 VT episodes during a mean follow-up of 131 days. A total
of 2347 VT episodes were recorded (33+65 episodes/patient, median 10 episodes /
patient). Patient age 66+13 years, 78% male, 83% coronary artery disease, ejection frac-
tion 31+11%, 63% taking antiarrhythmic drugs. The inter-event interval was less than 1
hour for 78% of all intervals and was less than 91 hours for 94% of inter-event intervals.
By the Kolmogorov Smirnov goodness-of-fit test, 38 out of 71 patients (53.5%) showed
that the distribution of inter-detection intervals differed from an exponential model (p <
0.01 for each patient, p = 0.65 for proportion of patients similar to chance), while only 11
out of 71 patients (15.5%) showed that the distribution of inter-detection intervals differed
from a Weibull model (p < 0.01 for each patient, p < 0.001 for proportion of patients simi-
lar to chance). CONCLUSION: The recurrence pattern of treated VT events in ICD
patients are clustered and are more frequently described by a Weibull distribution than a
random distribution. The time between consecutive treated VT detections is usually < 1
hour and infrequently > 91 hours. Knowledge of this pattern may help to design studies of
new antiarrhythmic therapies.
1053-213 The Predictive Value of Electrophysiologic Testing: 
Subgroup Analysis in the Dual Chamber and VVI 
Implantable Defibrillator (DAVID) Trial
Nicholas G. Tullo, Anil K. Bhandari, Anne H. Dougherty, G. Stephen Greer, Maribel 
Hernandez, Gregory Michaud, Alfred Hallstrom, Anna O. Leonen, Ellen G. Renfroe, and 
the DAVID Investigators, University of Washington, Seattle, WA
Background: The DAVID Trial evaluated whether dual-chamber pacing was superior to
single chamber pacing in patients (pts) with an ejection fraction of less than 40% who
were receiving an implantable cardioverter-defibrillator (ICD). The result of a baseline
electrophysiologic study (EPS) in trial pts was reviewed to determine if inducibility of ven-
tricular arrhythmias predicted outcome.
Methods: A total of 506 pts were enrolled in the DAVID Trial. Baseline EPS was recom-
mended but not required except for pts enrolled because of unexplained syncope. The
induction protocol involved up to 3 premature extrastimuli at 2 drive cycle lengths from up
to 2 sites in the right ventricle. Induced arrhythmias were classified based on morphology,
rate, and duration.
Results: Of the pts enrolled in the trial, 313 had a baseline EPS. A comparison of demo-
graphic and clinical parameters between the pts who underwent EPS and those who did
not revealed few substantial differences. At the time of EPS 81% of pts were on drug
therapy, including 60% who were on beta blockers, 29% on digoxin, 10% on calcium
blockers, and 15% on Class I or III antiarrhythmic drugs. The worst arrhythmia induced
was sustained VF in 40 pts, sustained monomorphic VT > 250 bpm in 72 pts, sustained
monomorphic VT 201-250 bpm in 106 pts, sustained monomorphic VT 150-200 bpm in
34 pts, sustained monomorphic VT < 150 bpm in 10 pts, sustained polymorphic VT in 31
pts, non-sustained polymorphic VT in 5 pts, non-sustained monomorphic VT in 3 pts,
less than 15 beats of VT in 3 pts, and no VT in 9 pts. Kaplan-Meier survival analysis
showed no significant difference between inducibility or non-inducibility of the rhythm
classifications with respect to the time to first recurrent arrhythmia, time to first inappro-
priate therapy or time to first re-hospitalization, but time to the primary endpoint (death or
hospitalization for congestive heart failure) was shorter for non-inducible patients and
longest for patients with VF or polymorphic VT induced (p=.01).
Conclusion: In the DAVID pts who underwent EPS, inducibility of VT/VF appears to pre-
dict outcome with regard to survival / hospitalization for heart failure, but not for future
ICD therapies or hospitalization in general.
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1071-207 Expedited Geometric Rendering of Left Atrium and 
Pulmonary Veins Using Multipoint Electroanatomical 
Mapping
Martin D. Lowe, Laurie A. Peterson, Douglas L. Packer, Mayo Clinic, Rochester, MN
Background: Conventional electroanatomic mapping of the left atrium (LA) and pulmo-
nary veins (PVs) can be both time-consuming and laborious. An accelerated mapping
capability with simultaneous acquisition of multiple points would be clearly advantageous
in facilitating AF ablation.
Methods: We compared integrated multipoint electroanatomical mapping and geometric
rendering of LA and PVs with tip mapping alone in 17 patients undergoing AF ablation.
Eight patients (3 paroxysmal, 5 persistent AF) underwent mapping of LA and each PV
with a multipolar catheter (QwikStar, Biosense), that allowed simultaneous acquisition of
tip, shaft and trace point data from its distal 6 cm. Nine patients who underwent tip map-
ping alone (NaviStar, Biosense), were used as controls. Study patients had an ejection
fraction of 48 ± 16 %, an LA size of 44 ± 3 mm, and had failed 3.1 ± 1.3 antiarrhythmic
drugs, all values similar to controls.
Results: The LA was mapped and geometrically rendered much faster in study patients
than controls (11 ± 5.8 vs. 23 ± 12 minutes). In addition, multipoint mapping with 53 ± 29
tip, 83 ± 31 shaft and 84 ± 117 trace points required less catheter manipulation than con-
trol patients where 111 ± 57 tip points were needed for adequate rendering of LA anat-
omy. In study patients PV mapping required 3.5 ± 2.1 minutes with the LSPV rendered
using 22 ± 7 tip points and 76 ± 41 shaft points, LIPV 25 ± 8 and 69 ± 43, RSPV 24 ± 6
and 49 ± 36, and RIPV 20 ± 6 and 44 ± 30, tip and shaft points. PV trace points were not
required to obtain optimal venous geometry. In controls PVs were mapped in 3.4 ± 2.8
minutes per vein with 62 ± 28 tip points. Although PV mapping times were similar in both
groups, simultaneous multipoint mapping required less catheter movement and tip point
acquisition. The greater number of points in LA and PVs obtained in the study group
allowed for a more qualitatively precise geometric rendering of LA and PVs with clearer
demarcation of PV ostia.
Conclusion: This study demonstrates substantial reduction in LA mapping time by inte-
grated tip and shaft point mapping. The creation of a more anatomically correct rendering
of the LA-PV junction may facilitate ablative intervention, with improved targeting of
energy delivery.
1071-208 Circumferential and Combined Technique in 
Cryoisolation of Pulmonary Veins: The "Arctic Circler" 
Experience
Juergen Vogt, Johannes Heintze, Helga Buschler, Peter Schwartze, Dieter Horstkotte, 
Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany
Discrete sequential single pulsed isolation of the pulmonary veins (PV) with radiofre-
quency (RF) or cryotechnique with a 6-mm tip catheter is associated with many ostial
impulses and in RF with the risk of PV stenoses.
Guided by a 20-pole Lasso catheter before and after ablation, proximal PV isolation was
performed using the self-expanding arctic circler (AC) with a maximum of 30 mm in diam-
eter over 4 minutes of cryoimpulses (CI) at a temperature of -75 °C to -90°C (with N2O
cryo technique). Electrical gaps were closed under Lasso guidance using a 6-mm tip cry-
ocatheter (freezor xtra, Cryocath, Canada).
Of 35 patients (P) (9 women, age 59±7 years refractory to antiarrhythmic therapy, 33 with
paroxysmal, 2 with persistent atrial fibrillation (AF), mean duration 87±70 months) 22
were treated in a first attempt, 13 after ablation 3 months ago because of AF recurrence.
Of 125 PV 15 were re-isolated with the 6-mm tip cryocatheter because of single or few
inputs only. One hundred and ten PV were isolated with the arctic circler alone in 54%
(59 PV), with additional gap closing by the freezor in 46% (51 PV). Gap closing was more
(70%) required in the left upper PV (Table). There were no acute PV stenoses nor
stenoses after 3 months.
Conclusion: AC isolation of PV is successful in 54% with few CI only and in 100% with
additional gap closing with a conventional cryoablation.
1071-219 Remodeling of the Left Atrium and Pulmonary Veins 
Following Catheter Ablation of Atrial Fibrillation
Darshan Dalal, Vinod Jayam, Chandrasekhar R. Vasamreddy, Lars Lickfett, Dave 
Bradley, Zayd Eldadah, Timm Dickfeld, Henry Halperin, Ronald Berger, Hugh Calkins, 
Johns Hopkins University School of Medicine, Baltimore, MD
Background: Catheter ablation of atrial fibrillation (AF) has been shown to be a curative
approach for treatment of AF. The purpose of this study was to determine to what extent
catheter ablation of AF results in reverse remodeling of left atrial and pulmonary vein
(PV) size.
Methods: The patient population was comprised of 54 patients (40 male, 54+11 years)
who underwent catheter ablation for AF. Each patient had a gadolinium enhanced mag-
netric resonance scan prior to and 6-8 weeks following ablation. The diameters of the
PVs and the oblique axial, coronal, and sagital dimensions of the left atrium were deter-
mined. The left atrial volume was then calculated.
Results: The mean ± SD decrease in LA Volume was 12 ± 22% (p<0.001). The mean ±
SD decrease (mm) in the PV diameter was from 18.1 ± 2.9 to 16.6 ± 3.1 in Left Superior
(LS) PV, 17.5 ± 3.2 to 15.4 ± 4.0 in Left Inferior (LI) PV, 19.5 ± 3.5 to 17.1 ± 4.1 for Right
Superior (RS) PV and 19.0 ± 3.8 to 17.8 ± 4.3 in Right Inferior (RI) PV (p<0.01 for each).
LA volume change had a linear correlation with the reduction in diameter of each of the
four PVs. Percent change in diameter of each PV ostium showed correlation with percent
change in diameter of the other ostia except for LSPV and RIPV (figure). Overall, percent
change in diameter of ostia of all PVs correlated with the percent change in LA volume
(p<0.01).
Tab. 1
Targeted PV Cryoimpulses 
with AC
Isolation AC Isolation
AC + 
Freezor
Cryoimpulses 
Freezor
Isolation
%
Diameter
mm
Left upper (n=31) 5.4±1.6 11 (30%) 20 6.4±5 100 18±4
Left lower (n=23) 3.6±1.1 15 (65%) 8 5.0±2 100 17±2
Right upper (n=29) 4.4±1.4 17 (58%) 12 5.0±3 100 17±3
Right lower (n=27) 3.3±0.9 16 (59%) 11 4.0±2 100 17±3
